US4602022A
Expired / Lapsed
US
⏱️ 0.0 years remaining
N-imidazolyl derivatives of bicyclic compounds
Assignee: Pfizer Italia SRL
•
Filing: 1984-11-21
•
Granted: 1986-07-22
•
Expires: 2004-11-21
Abstract
Abstract Compounds of the formula (I) <IMAGE> (I) wherein the symbol represents a single or a double bond; each of R1, R2, R3 and R4, which may be the same or different is (a) hydrogen; hydroxy; halogen; cyano; C1-C6 alkyl; C1-C6 alkoxy; a C2-C4 acyl or C2-C4 acylamino group; -SR', -N(R') (R''), -CH2OR', -COR or -CH2COR, wherein R is OR' or -N(R') (R'') and each of R' and R'', being the same or different, is hydrogen or C1-C6 alkyl; or (b) one of R1, R2, R3 and R4 is 5-tetrazolyl or a group selected from -COCH2OR', -CH=C(R')-COR and -X-C(R')(R'')-COR, wherein R, R' and R'' are as defined above, and X is -O-, -S-, or -NH-, and the others are as defined above under (a); R5 is hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, or a phenyl or 3-pyridyl ring, wherein the phenyl or pyridyl ring is unsubstituted or substituted by one to three substituents chosen from hydroxy and C1-C4 alkoxy; or pharmaceutically acceptable salt thereof exhibit pharmaceutical activity as vasodilators or blood platelet aggregation inhibitors. Additionally, these compounds and their pharmaceutically acceptable salts are useful in the treatment of migraine, diabetic microangiopathy, rheumatoid arthritis, hypertension, peptic ulcers, osteoporosis, angina pectoris, atherosclerosis and dislipidaemies.
Inventors
- 👤 Paolo Cozzi
- 👤 Germano Carganico
- 👤 Antonio Pillan
- 👤 Umberto Branzoli
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 01:15
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; A; A61; A61P; A61P1/00; A61P1/04; A61P25/00; A61P25/04; A61P25/06; A61P29/00; A61P3/00; A61P3/06; A61P7/00; A61P7/02; A61P9/00; A61P9/10; A61P9/12; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
203 words
A compound of general formula (I) ##STR56## wherein the symbol represents a single or a double bond; each of R 1 , R 2 , R 3 and R 4 , which may be the same or different, is (a) hydrogen; hydroxy; halogen; cyano; C 1 -C 6 alkyl; C 1 -C 6 alkoxy; a C 2 -C 4 acyl or C 2 -C 4 acylamino group; --SR', ##STR57## --CH 2 OR', --COR or --CH 2 COR, wherein R is --OR' or ##STR58## and each of R' and R", being the same or different, is hydrogen or C 1 -C 6 alkyl; or (b) one of R 1 , R 2 , R 3 and R 4 is 5-tetrazolyl or a group selected from --COCH 2 OR', ##STR59## wherein R, R' and R" are as defined above, and X is --O--, --S-- or --NH--, and the others are as defined above under (a); R 5 is hydrogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, or a phenyl or 3-pyridyl ring, wherein the phenyl or pyridyl ring is unsubstituted or substituted by one to three substituents chosen from hydroxy and C 1 -C 4 alkoxy; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
203 words
A compound of general formula (I) ##STR56## wherein the symbol represents a single or a double bond; each of R 1 , R 2 , R 3 and R 4 , which may be the same or different, is (a) hydrogen; hydroxy; halogen; cyano; C 1 -C 6 alkyl; C 1 -C 6 alkoxy; a C 2 -C 4 acyl or C 2 -C 4 acylamino group; --SR', ##STR57## --CH 2 OR', --COR or --CH 2 COR, wherein R is --OR' or ##STR58## and each of R' and R", being the same or different, is hydrogen or C 1 -C 6 alkyl; or (b) one of R 1 , R 2 , R 3 and R 4 is 5-tetrazolyl or a group selected from --COCH 2 OR', ##STR59## wherein R, R' and R" are as defined above, and X is --O--, --S-- or --NH--, and the others are as defined above under (a); R 5 is hydrogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, or a phenyl or 3-pyridyl ring, wherein the phenyl or pyridyl ring is unsubstituted or substituted by one to three substituents chosen from hydroxy and C 1 -C 4 alkoxy; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
162 words
A compound of claim 1, wherein the symbol represents a double bond; each of R 1 , R 2 , R 3 and R 4 , which may be the same or different, is (a') hydrogen, hydroxy, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, --CH 2 OH, --COOR a or ##STR60## wherein each of R a and R b is independently hydrogen, or C 1 -C 4 alkyl; or (b') one of R 1 , R 2 , R 3 and R 4 is C 2 -C 4 acyl, --CH 2 COOR a , ##STR61## wherein R a and R b are as defined above, and the others are as defined above under (a'): R 5 is hydrogen, and the other is hydrogen, C 1 -C 3 alkyl, cyclopropyl, or a phenyl or 3-pyridyl ring unsubstituted or substituted by one to three substituents chosen from hydroxy and C 1 -C 2 alkoxy; or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim
105 words
A compound of claim 1 wherein the symbol represents a double bond; one of R 1 , R 2 , R 3 and R 4 is --COOR a , wherein R a is as defined in claim 2, and the others are independently chosen from hydrogen and hydroxy; or one of R 1 , R 2 , R 3 and R 4 is --CONH 2 , --CH 2 OH, --COCH 3 , --CH 2 COOR a , ##STR62## wherein R a and R b are as defined in claim 2, and the others are hydrogen; R 5 is hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim
67 words
A compound of claim 1, wherein the symbol represents a double bond; one of R 1 , R 2 , R 3 and R 4 is ##STR63## wherein R g is is --NH 2 or --OR a and R a and R b are independently hydrogen or C 1 -C 4 alkyl, and the others are hydrogen; R 5 is hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim
47 words
A compound selected from the group consisting of: 3-(1-imidazolyl)-2H-1-benzopyran; 3-(1-imidazolyl)-6-chloro-2H-1-benzopyran; 3-(1-imidazolyl)-6-methoxy-2H-1-benzopyran; 3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 3-(1-imidazolyl)-6-(2-carboxyisopropoxy)-2H-1-benzopyran; 3-(1-imidazolyl)-6-(2-carboxyvinyl)-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-methoxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-7-carboxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-carbamoyl-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-(2-carboxyvinyl)-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-(2-carboxyisopropoxy)-2H-1-benzopyran; 2-isopropyl-3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-ethoxycarbonyl-2H-1-benzopyran; 2-cyclopropyl-3-(1-imidazolyl)-6-carboxyl-2H-1-benzopyran; 2-(3,4-dimethoxyphenyl)-3-(1-imidazolyl)-6-methoxy-2H-1-benzopyran; 2-(3,4-dihydroxyphenyl)-3-(1-imidazolyl)-6-hydroxy-2H-1-benzopyran; 2-(3-pyridyl)-3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 2-(4-hydroxyphenyl)-3-(1-imidazolyl)-5,7-dihydroxy-2H-1-benzopyran; 3,4-dihydro-3-(1-imidazolyl)-6-carboxy-1-benzopyran; 3,4-dihydro-2-methyl-3-(1-imidazolyl)-6-carboxy-1-benzopyran; 3,4-dihydro-2-methyl-3-(1-imidazolyl)-6-(2-carboxyvinyl)-1-benzopyran; or a pharmaceutically acceptable salt thereof, or, when appropriate, a C 1 -C 4 alkyl ester thereof.
Claim 7
Dependent Claim
47 words
A compound selected from the group consisting of: 3-(1-imidazolyl)-2H-1-benzopyran; 3-(1-imidazolyl)-6-chloro-2H-1-benzopyran; 3-(1-imidazolyl)-6-methoxy-2H-1-benzopyran; 3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 3-(1-imidazolyl)-6-(2-carboxyisopropoxy)-2H-1-benzopyran; 3-(1-imidazolyl)-6-(2-carboxyvinyl)-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-methoxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-7-carboxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-carbamoyl-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-(2-carboxyvinyl)-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-(2-carboxyisopropoxy)-2H-1-benzopyran; 2-isopropyl-3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 2-methyl-3-(1-imidazolyl)-6-ethoxycarbonyl-2H-1-benzopyran; 2-cyclopropyl-3-(1-imidazolyl)-6-carboxyl-2H-1-benzopyran; 2-(3,4-dimethoxyphenyl)-3-(1-imidazolyl)-6-methoxy-2H-1-benzopyran; 2-(3,4-dihydroxyphenyl)-3-(1-imidazolyl)-6-hydroxy-2H-1-benzopyran; 2-(3-pyridyl)-3-(1-imidazolyl)-6-carboxy-2H-1-benzopyran; 2-(4-hydroxyphenyl)-3-(1-imidazolyl)-5,7-dihydroxy-2H-1-benzopyran; 3,4-dihydro-3-(1-imidazolyl)-6-carboxy-1-benzopyran; 3,4-dihydro-2-methyl-3-(1-imidazolyl)-6-carboxy-1-benzopyran; 3,4-dihydro-2-methyl-3-(1-imidazolyl)-6-(2-carboxyvinyl)-1-benzopyran; or a pharmaceutically acceptable salt thereof, or, when appropriate, a C 1 -C 4 alkyl ester thereof.
Claim 8
Dependent Claim
25 words
A pharmaceutical composition for inducing vasodilation comprising a suitable carrier or diluent and a vasodilatory effective amount of the compound as claimed in claim 1.
Claim 9
Dependent Claim
29 words
A pharmaceutical composition for inhibiting blood platelete aggregation comprising a suitable carrier or diluent and a blood platelet antiaggregatory effective amount of the compound as claimed in claim 1.
Claim 10
Dependent Claim
27 words
A pharmaceutical composition for the treatment of migraine comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 11
Dependent Claim
28 words
A pharmaceutical composition for the treatment of diabetic microangiopathy comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 12
Dependent Claim
28 words
A pharmaceutical composition for the treatment of rheumatoid arthritis comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 13
Dependent Claim
27 words
A pharmaceutical composition for the treatment of hypertension comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 14
Dependent Claim
28 words
A pharmaceutical composition for the treatment of peptic ulcers comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 15
Dependent Claim
27 words
A pharmaceutical composition for the treatment of osteoporosis comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 16
Dependent Claim
28 words
A pharmaceutical composition for the treatment of angina pectoris comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 17
Dependent Claim
27 words
A pharmaceutical composition for the treatment of atherosclerosis comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 18
Dependent Claim
27 words
A pharmaceutical composition for the treatment of dislipidaemies comprising a suitable carrier or diluent and a therapeutically effective amount of the compound as claimed in claim 1.
Claim 19
Dependent Claim
25 words
A method of treating atherosclerosis in a patient comprising administering to the patient a therapeutically effective amount of the compound as claimed in claim 1.
Claim 20
Dependent Claim
25 words
A method of treating dislipidaemics in a patient comprising administering to the patient a therapeutically effective amount of the compound as claimed in claim 1.
References Cited (Backward Citations)
NL6705095A
Cited
US3485917A
Cited
US3541109A
Cited
US3637731A
Cited
BE827870A
Cited
US4006243A
Cited
EP0000951A1
Cited
JPS5681566A
Cited
BE887766A
Cited
US4342775A
Cited
BE893917A
Cited
US4492707A
Cited
EP0073663A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-07-21 | 1990-01-20 | 1990-07-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-07-21 | 1994-01-20 | 1994-07-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-07-21 | 1998-01-20 | 1998-07-22 | $7700.00 | Window Closed / Lapsed |